Naloxone hydrochloride 5 mg / oxycodone hydrochloride 10 mg Extended Release Oral Tablet [Targiniq]
RxNorm 1546090
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1546090 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: naloxone hydrochloride 5 mg / oxycodone hydrochloride 10 mg Extended Release Oral Tablet [Targiniq].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Naloxone hydrochloride 5 mg / oxycodone hydrochloride 10 mg Extended Release Oral Tablet [Targiniq]
(Atom ID: 12361285)
TMSY